Literature DB >> 27342248

The Promoting Effect of Radiation on Glucose Metabolism in Breast Cancer Cells under the Treatment of Cobalt Chloride.

Chun-Bo Zhao1, Lei Shi2, Hai-Hong Pu3, Qing-Yuan Zhang4.   

Abstract

We aimed to investigate the influence of radiation on hypoxia-treated breast cancers cells and its underlying mechanism. We mimicked the hypoxic response in MCF-7 cells by the treatment of CoCl2. Meanwhile, hypoxic MCF-7 cells induced by CoCl2 or untreated MCF-7 cells were treated with or without radiation, and then treated with or without hypoxia inducible factors-1α (HIF-1α) inhibitor. Subsequently, glucose update and lactate release rate were determined by commercial kits, as well as the expressions of HIF-1α and the glucose metabolic pathway related genes, including fructose biphoshatase 1 (FBP1), glucose transporter 1 (GLUT1), lactate dehydrogenase A (LDHA), hexokinase 2 (HK2), and isocitrate dehydrogenase 2 (IDH20) were detected by western blotting and/or RT-PCR. The results showed that glucose uptake rate and lactate release rate were increased in cells under hypoxia and/or radiation condition compared with untreated cells (p < 0.05), while the addition of HIF-1α inhibitor decreased these rates in hypoxia + radiation treated cells (p < 0.05). In addition, compared with untreated cells, the mRNA and protein levels of HIF-1α were significantly increased under hypoxia and radiation condition (p < 0.05), while which decreased after the addition of HIF-1α inhibitor (p < 0.05). Similar content changing trends (all p < 0.05) were observed in FBP1, IDH2, GLUT1, and LDHA but not HK2. In conclusion, the combination of radiation and hypoxia could promote the glucose metabolism. Furthermore, HIF-1α might inhibit the promoting effect of radiation on glycolysis in hypoxic MCF-7 cells by regulating the glucose metabolic pathway.

Entities:  

Keywords:  Cancer cell; Glucose metabolism; Hypoxia inducible factors-1α; Radiation; hypoxia

Mesh:

Substances:

Year:  2016        PMID: 27342248     DOI: 10.1007/s12253-016-0076-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  39 in total

1.  Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.

Authors:  A Behrooz; F Ismail-Beigi
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

2.  Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.

Authors:  B H Jiang; J Z Zheng; S W Leung; R Roe; G L Semenza
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

Review 3.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 4.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

Review 5.  Molecular imaging of hypoxia with radiolabelled agents.

Authors:  Gilles Mees; Rudi Dierckx; Christel Vangestel; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-30       Impact factor: 9.236

Review 6.  Investigating hypoxic tumor physiology through gene expression patterns.

Authors:  Nicholas C Denko; Lucrezia A Fontana; Karen M Hudson; Patrick D Sutphin; Soumya Raychaudhuri; Russ Altman; Amato J Giaccia
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

7.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

8.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.

Authors:  N S Chandel; E Maltepe; E Goldwasser; C E Mathieu; M C Simon; P T Schumacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

9.  The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function.

Authors:  L C J Baker; J K R Boult; S Walker-Samuel; Y-L Chung; Y Jamin; M Ashcroft; S P Robinson
Journal:  Br J Cancer       Date:  2012-04-12       Impact factor: 7.640

10.  BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.

Authors:  Peter Ellinghaus; Iring Heisler; Kerstin Unterschemmann; Michael Haerter; Hartmut Beck; Susanne Greschat; Alexander Ehrmann; Holger Summer; Ingo Flamme; Felix Oehme; Karlheinz Thierauch; Martin Michels; Holger Hess-Stumpp; Karl Ziegelbauer
Journal:  Cancer Med       Date:  2013-08-20       Impact factor: 4.452

View more
  2 in total

Review 1.  IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders.

Authors:  Ya Qi Gong; Shuang Wei; Yuan Yun Wei; Yong Lin Chen; Jian Cui; Yue Qiu Yu; Xiang Lin; Hong Xia Yan; Hui Qin; Lan Yi
Journal:  Oncol Lett       Date:  2022-06-24       Impact factor: 3.111

2.  5-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells.

Authors:  Takuya Owari; Nobumichi Tanaka; Yasushi Nakai; Makito Miyake; Satoshi Anai; Shingo Kishi; Shiori Mori; Rina Fujiwara-Tani; Yudai Hojo; Takuya Mori; Masaomi Kuwada; Tomomi Fujii; Masatoshi Hasegawa; Kiyohide Fujimoto; Hiroki Kuniyasu
Journal:  Br J Cancer       Date:  2022-04-01       Impact factor: 9.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.